Connecting the dots from Toll-like receptors to innate immune cells and inflammatory bowel disease.
Boone
David L
DL
Department of Medicine, Ben May Institute for Cancer Research, The University of Chicago, Chicago, Illinois 60637, USA. ama@medicine.bsd.uchicago.edu
Ma
Averil
A
D000818:Animals; D016207:Cytokines / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism; D029721:Drosophila Proteins; D006801:Humans; D007107:Immune System / Q000166:cytology*; D015212:Inflammatory Bowel Diseases / Q000276:immunology* / Q000378:metabolism*; D008070:Lipopolysaccharides / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism*; D008954:Models, Biological; D011956:Receptors, Cell Surface / Q000378:metabolism*; D050796:STAT3 Transcription Factor; D015398:Signal Transduction / Q000502:physiology; D051193:Toll-Like Receptors; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism
D016207:Cytokines; D004268:DNA-Binding Proteins; D029721:Drosophila Proteins; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D011956:Receptors, Cell Surface; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; D051193:Toll-Like Receptors; D015534:Trans-Activators